Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 2001 Aug;71(2):200–204. doi: 10.1136/jnnp.71.2.200

Peripheral neuropathy in chronic occupational inorganic lead exposure: a clinical and electrophysiological study

O Rubens 1, I Logina 1, I Kravale 1, M Eglite 1, M Donaghy 1
PMCID: PMC1737511  PMID: 11459892

Abstract

BACKGROUND AND OBJECTIVES—Traditionally the neuromuscular disorder associated with lead poisoning has been purely motor. This study assessed peripheral nerve function clinically and electrophysiologically in 46 patients with neuropathic features out of a total population of 151 workers with raised blood and/or urinary lead concentrations.
RESULTS—Average duration of occupational exposure for the neuropathic group ranged from 8-47 years (mean 21.7). Their mean blood lead concentration (SD) was 63.9 (18.3) µg/dl (normal <40), urinary lead 8.6 (3.3) µg/dl (normal<5.0), urinary coproporphyrins 66.7(38.4) µg/g creatinine (20-80), urinary aminolaevulinic acid 1.54(0.39) mg/g creatinine (0.5-2.5). All 46 had distal paraesthesiae, pain, impaired pin prick sensation, diminished or absent ankle jerks, and autonomic vasomotor or sudomotor disturbances. Reduced vibration sensation and postural hypotension were present in all 20 studied. None of these 46 patients had motor anormalities. Motor conduction velocity and compound muscle action potential amplitudes were normal, with marginally prolonged distal motor latencies. Sensory nerve action potential amplitudes lay at the lower end of the normal range, and the distal sensory latencies were prolonged. No direct correlation was found between the biochemical variables, and the clinical or electrophysiological data.
CONCLUSIONS—One additional patient was seen with shorter term exposure to lead fumes with subacute development of colicky abdominal pain, severe limb weakness, and only minor sensory symptoms. Unlike the patients chronically exposed to lead, he had massively raised porphyrins (aminolaevulinic acid 21 mg/g creatinine, coproporhyrins 2102 µg/g creatinine). Patients with unusually long term inorganic lead exposure showed mild sensory and autonomic neuropathic features rather than the motor neuropathy classically attributed to lead toxicity. It is proposed that the traditional motor syndrome associated with subacute lead poisoning is more likely to be a form of lead induced porphyria rather than a direct neurotoxic effect of lead.



Full Text

The Full Text of this article is available as a PDF (132.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albers J. W., Kallenbach L. R., Fine L. J., Langolf G. D., Wolfe R. A., Donofrio P. D., Alessi A. G., Stolp-Smith K. A., Bromberg M. B. Neurological abnormalities associated with remote occupational elemental mercury exposure. Ann Neurol. 1988 Nov;24(5):651–659. doi: 10.1002/ana.410240510. [DOI] [PubMed] [Google Scholar]
  2. Araki S., Honma T., Yanagihara S., Ushio K. Recovery of slowed nerve conduction velocity in lead-exposed workers. Int Arch Occup Environ Health. 1980;46(2):151–157. doi: 10.1007/BF00378193. [DOI] [PubMed] [Google Scholar]
  3. Bosch E. P., Pierach C. A., Bossenmaier I., Cardinal R., Thorson M. Effect of hematin in porphyric neuropathy. Neurology. 1977 Nov;27(11):1053–1056. doi: 10.1212/wnl.27.11.1053. [DOI] [PubMed] [Google Scholar]
  4. Buchthal F., Behse F. Electrophysiology and nerve biopsy in men exposed to lead. Br J Ind Med. 1979 May;36(2):135–147. doi: 10.1136/oem.36.2.135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Catton M. J., Harrison M. J., Fullerton P. M., Kazantzis G. Subclinical neuropathy in lead workers. Br Med J. 1970 Apr 11;2(5701):80–82. doi: 10.1136/bmj.2.5701.80. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cullen M. R., Robins J. M., Eskenazi B. Adult inorganic lead intoxication: presentation of 31 new cases and a review of recent advances in the literature. Medicine (Baltimore) 1983 Jul;62(4):221–247. [PubMed] [Google Scholar]
  7. Davis L. E., Standefer J. C., Kornfeld M., Abercrombie D. M., Butler C. Acute thallium poisoning: toxicological and morphological studies of the nervous system. Ann Neurol. 1981 Jul;10(1):38–44. doi: 10.1002/ana.410100108. [DOI] [PubMed] [Google Scholar]
  8. Di Trapani G., Casali C., Tonali P., Topi G. C. Peripheral nerve findings in hereditary coproporphyria. Light and ultrastructural studies in two sural nerve biopsies. Acta Neuropathol. 1984;63(2):96–107. doi: 10.1007/BF00697191. [DOI] [PubMed] [Google Scholar]
  9. Dyer J., Garrick D. P., Inglis A., Pye I. F. Plumboporphyria (ALAD deficiency) in a lead worker: a scenario for potential diagnostic confusion. Br J Ind Med. 1993 Dec;50(12):1119–1121. doi: 10.1136/oem.50.12.1119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Feldman R. G., Niles C. A., Kelly-Hayes M., Sax D. S., Dixon W. J., Thompson D. J., Landau E. Peripheral neuropathy in arsenic smelter workers. Neurology. 1979 Jul;29(7):939–944. doi: 10.1212/wnl.29.7.939. [DOI] [PubMed] [Google Scholar]
  11. Mitchell C. S., Shear M. S., Bolla K. I., Schwartz B. S. Clinical evaluation of 58 organolead manufacturing workers. J Occup Environ Med. 1996 Apr;38(4):372–378. doi: 10.1097/00043764-199604000-00015. [DOI] [PubMed] [Google Scholar]
  12. Oh S. J. Lead neuropathy: case report. Arch Phys Med Rehabil. 1975 Jul;56(7):312–317. [PubMed] [Google Scholar]
  13. Ridley A. The neuropathy of acute intermittent porphyria. Q J Med. 1969 Jul;38(151):307–333. [PubMed] [Google Scholar]
  14. SETO D. S., FREEMAN J. M. LEAD NEUROPATHY IN CHILDHOOD. Am J Dis Child. 1964 Apr;107:337–342. doi: 10.1001/archpedi.1964.02080060339003. [DOI] [PubMed] [Google Scholar]
  15. SIMPSON J. A., SEATON D. A., ADAMS J. F. RESPONSE TO TREATMENT WITH CHELATING AGENTS OF ANAEMIA, CHRONIC ENCEPHALOPATHY, AND MYELOPATHY DUE TO LEAD POISONING. J Neurol Neurosurg Psychiatry. 1964 Dec;27:536–541. doi: 10.1136/jnnp.27.6.536. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Seppäläinen A. M., Hernberg S. Sensitive technique for detecting subclinical lead neuropathy. Br J Ind Med. 1972 Oct;29(4):443–449. doi: 10.1136/oem.29.4.443. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Seppäläinen A. M., Tola S., Hernberg S., Kock B. Subclinical neuropathy at "safe" levels of lead exposure. Arch Environ Health. 1975 Apr;30(4):180–183. doi: 10.1080/00039896.1975.10666672. [DOI] [PubMed] [Google Scholar]
  18. Soulsby J., Smith R. L. A simplified method for the quantitative determination of urinary coproporphyrin in lead workers. Br J Ind Med. 1974 Jan;31(1):72–74. doi: 10.1136/oem.31.1.72. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Straka J. G., Rank J. M., Bloomer J. R. Porphyria and porphyrin metabolism. Annu Rev Med. 1990;41:457–469. doi: 10.1146/annurev.me.41.020190.002325. [DOI] [PubMed] [Google Scholar]
  20. Suarez J. I., Cohen M. L., Larkin J., Kernich C. A., Hricik D. E., Daroff R. B. Acute intermittent porphyria: clinicopathologic correlation. Report of a case and review of the literature. Neurology. 1997 Jun;48(6):1678–1683. doi: 10.1212/wnl.48.6.1678. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES